The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABIVAX SA | SPONSORED ADS | 00370M103 | 80,622,300 | 605,000 | SH | SOLE | 605,000 | 0 | 0 | ||
| ALLOGENE THERAPEUTICS INC | COM | 019770106 | 3,120,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
| AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | 14,368,000 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
| AN2 THERAPEUTICS INC | COM | 037326105 | 3,625,329 | 749,035 | SH | SOLE | 749,035 | 0 | 0 | ||
| APOGEE THERAPEUTICS INC | COM | 03770N101 | 9,291,100 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
| AVALO THERAPEUTICS INC | COM NEW | 05338F306 | 6,930,000 | 375,000 | SH | SOLE | 375,000 | 0 | 0 | ||
| CAPRICOR THERAPEUTICS INC | COM NEW | 14070B309 | 33,595,356 | 1,395,156 | SH | SOLE | 1,395,156 | 0 | 0 | ||
| CELCUITY INC | COM | 15102K100 | 43,577,368 | 416,530 | SH | SOLE | 416,530 | 0 | 0 | ||
| CLENE INC | COM NEW | 185634201 | 2,939,105 | 477,515 | SH | SOLE | 477,515 | 0 | 0 | ||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | 8,707,500 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
| CONTINEUM THERAPEUTICS INC | CL A | 21217B100 | 8,096,660 | 494,000 | SH | SOLE | 494,000 | 0 | 0 | ||
| CORCEPT THERAPEUTICS INC | COM | 218352102 | 29,171,725 | 335,500 | SH | SOLE | 335,500 | 0 | 0 | ||
| CORVUS PHARMACEUTICALS INC | COM | 221015100 | 16,434,000 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
| CRESCENT BIOPHARMA INC. | COM | 38000Q201 | 8,166,348 | 453,686 | SH | SOLE | 453,686 | 0 | 0 | ||
| CYBIN INC | COM NEW | 23256X407 | 5,221,900 | 790,000 | SH | SOLE | 790,000 | 0 | 0 | ||
| CYTOKINETICS INC | COM NEW | 23282W605 | 8,519,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| DEFINIUM THERAPEUTICS INC | COM SHS | 24477V105 | 46,969,440 | 998,500 | SH | SOLE | 998,500 | 0 | 0 | ||
| EDESA BIOTECH INC | COM NEW | 27966L306 | 1,666,650 | 205,000 | SH | SOLE | 205,000 | 0 | 0 | ||
| FAETH THERAPEUTICS inc | COM NEW | 81728A207 | 4,512,625 | 180,505 | SH | SOLE | 180,505 | 0 | 0 | ||
| FORTE BIOSCIENCES INC | COM NEW | 34962G208 | 5,833,125 | 274,500 | SH | SOLE | 274,500 | 0 | 0 | ||
| IMMATICS N.V | SHS | N44445109 | 4,811,750 | 475,000 | SH | SOLE | 475,000 | 0 | 0 | ||
| INOVIO PHARMACEUTICALS INC | COM SHS | 45773H409 | 3,129,493 | 2,844,994 | SH | SOLE | 2,844,994 | 0 | 0 | ||
| INVIVYD INC | COM | 00534A102 | 1,308,600 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
| KARYOPHARM THERAPEUTICS INC | COM NEW | 48576U205 | 2,955,777 | 302,536 | SH | SOLE | 302,536 | 0 | 0 | ||
| KAZIA THERAPEUTICS LTD | SPONSORED ADS | 48669G303 | 7,884,800 | 560,000 | SH | SOLE | 560,000 | 0 | 0 | ||
| KODIAK SCIENCES INC | COM | 50015M109 | 57,567,296 | 1,477,600 | SH | SOLE | 1,477,600 | 0 | 0 | ||
| KYMERA THERAPEUTICS INC | COM | 501575104 | 49,204,897 | 429,100 | SH | SOLE | 429,100 | 0 | 0 | ||
| LB PHARMACEUTICALS INC | COM SHS | 50180M108 | 2,271,850 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
| MAPLIGHT THERAPEUTICS INC | COM | 56565P103 | 2,688,000 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 893,332 | 666,666 | SH | SOLE | 666,666 | 0 | 0 | ||
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 5,354,250 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
| NEUMORA THERAPEUTICS INC. | COM | 640979100 | 3,400,000 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
| NURIX THERAPEUTICS INC | COM | 67080M103 | 2,426,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| OCULAR THERAPEUTIX INC | COM | 67576A100 | 12,766,000 | 1,300,000 | SH | SOLE | 1,300,000 | 0 | 0 | ||
| ODYSSEY THERAPEUTICS INC | COMMON STOCK | 67613T104 | 5,145,250 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
| OPUS GENETICS INC | COM | 67577R102 | 11,569,650 | 2,815,000 | SH | SOLE | 2,815,000 | 0 | 0 | ||
| ORIC PHARMACEUTICALS INC | COM | 68622P109 | 3,790,500 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
| PALISADE BIO INC | COM | 696389402 | 10,031,739 | 4,799,875 | SH | SOLE | 4,799,875 | 0 | 0 | ||
| PEPGEN INC | COM | 713317105 | 491,206 | 272,892 | SH | SOLE | 272,892 | 0 | 0 | ||
| PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | 15,553,339 | 46,457 | SH | SOLE | 46,457 | 0 | 0 | ||
| PRECIGEN INC | COM | 74017N105 | 29,355,000 | 5,150,000 | SH | SOLE | 5,150,000 | 0 | 0 | ||
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 20,838,600 | 170,000 | SH | SOLE | 170,000 | 0 | 0 | ||
| PTC THERAPEUTICS INC | COM | 69366J200 | 16,314,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| Q32 BIO INC | COM | 746964105 | 40,122,209 | 3,149,310 | SH | SOLE | 3,149,310 | 0 | 0 | ||
| REGENXBIO INC | COM | 75901B107 | 179,700 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
| RELAY THERAPEUTICS INC | COM | 75943R102 | 8,419,500 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
| RELMADA THERAPEUTICS INC | COM | 75955J402 | 5,827,374 | 842,106 | SH | SOLE | 842,106 | 0 | 0 | ||
| REPLIMUNE GROUP INC | COM | 76029N106 | 44,091,810 | 3,983,000 | SH | SOLE | 3,983,000 | 0 | 0 | ||
| REVOLUTION MEDICINES INC | COM | 76155X100 | 93,640,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| SAREPTA THERAPEUTICS INC | COM | 803607100 | 2,695,500 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| SHATTUCK LABS INC | COM | 82024L103 | 6,940,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| SOLID BIOSCIENCES INC | COM NEW | 83422E204 | 2,997,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | 8,878,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | 4,025,250 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| Surrozen Inc. | COM NEW | 86889P208 | 26,963,591 | 1,105,683 | SH | SOLE | 1,105,683 | 0 | 0 | ||
| SURROZEN INC | *W EXP 08/01/203 | 86889P117 | 1,067 | 66,666 | SH | SOLE | 66,666 | 0 | 0 | ||
| TANGO THERAPEUTICS INC | COM | 87583X109 | 339,990,606 | 10,876,219 | SH | SOLE | 10,876,219 | 0 | 0 | ||
| UNIQURE NV | SHS | N90064101 | 69,241,998 | 1,503,300 | SH | SOLE | 1,503,300 | 0 | 0 | ||
| UPSTREAM BIO INC | COM | 91678A107 | 1,038,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| UROGEN PHARMA LTD | COM | M96088105 | 18,400,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| VAXCYTE INC | COM | 92243G108 | 18,892,250 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
| VIR BIOTECHNOLOGY INC | COM | 92764N102 | 19,014,540 | 1,866,000 | SH | SOLE | 1,866,000 | 0 | 0 | ||
| ZURA BIO LTD | CLASS A ORD SHS | G9TY5A101 | 5,310,000 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | ||